ANTHRACITE INVESTMENT COMPANY INC
Q2 2026 Form 13-F

FORT WORTH, TEXAS
CIK 0001809930 · Institutional investment manager
Holdings withheld — SEC confidential treatment
Reported value
$0
Quarter over quarter
0.0%
Holdings
0
Top-10 concentration
0.0%

Key People

Named on the latest Form 13-F filing — not necessarily an owner
William B. Holloway, Jr.
Chief Operating Officer

Filing Navigation

13F Metrics

Loading 13F Metrics

Holdings Withheld — SEC Confidential Treatment — Q2 2026

Anthracite Investment Company Inc filed a Form 13F-HR for Q2 2026, but requested confidential treatment from the SEC under Rule 24b-2 of the Securities Exchange Act of 1934. As a result, the filing contains no public holdings detail.

Confidential treatment is typically granted for up to a year to protect ongoing trading strategies — for example, while a manager is still accumulating a position. When the confidential period expires, the filer must submit an amendment disclosing the previously withheld holdings.


View SEC Filing Filed: August 10, 2026 · Accession: 0001213900-26-087282

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 2, 2026
0 $0
Q2 2026 13F
Filed Aug 10, 2026
0 $0
Q1 2026 13F
Filed May 6, 2026
0 $0
Q4 2025 13F
Filed Feb 12, 2026
0 $0
Q3 2025 13F
Filed Nov 5, 2025
0 $0
Q2 2025 13F
Filed Jul 31, 2025
63 $198.4M
Q1 2025 13F
Filed May 8, 2025
62 $179.6M
Q4 2024 13F
Filed Feb 12, 2025
81 $285.4M
Q3 2024 13F
Filed Nov 8, 2024
79 $225.6M
Q2 2024 13F
Filed Aug 8, 2024
75 $223.8M
Q1 2024 13F
Filed May 9, 2024
93 $274.1M
Q4 2023 13F
Filed Feb 8, 2024
75 $183.2M